What is the Projected CAGR value of the Non-Proliferative Diabetic Retinopathy Market?
Non-Proliferative Diabetic Retinopathy Market is expected to grow at a CAGR of 7.3% during the forecast period 2024-2031.
Who are the key players in the Non-Proliferative Diabetic Retinopathy Market ?
Major players are Abbott Laboratories, Alimera Science, Allergan plc, Ampio Pharmaceuticals., Bayer AG, F. Hoffmann-La Roche, Novartis International AG, Pfizer, Regeneron Pharmaceuticals Inc, and Valeant Pharmaceutical.